Author Archive: Abigail Hirsch

Abigail was the Director of Events Communications at BIO.

Latest Posts

Leading MIT Scientist, Professor and Entrepreneur, Robert Langer, to Speak at BIO 2015

BIO International Convention

In a recent Boston Globe article, MIT standout and Queen Elizabeth Prize for Engineering recipient, Robert Langer, discusses the highlights and challenges facing our industry. He emphasized all of the progressive work being done on the drug-delivery system, collaborations with the Bill Gates foundation for the Third World and the work on nanotechs in the lab, specifically trying to deliver different kinds of gene therapy and drugs in general. “There’s so much great work going Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

FOX Business: BIO CEO Jim Greenwood Discusses State of the Industry


BIO President and CEO Jim Greenwood recently appeared on Fox Business Risk & Reward with Deirdre Bolton to discuss the current state of the industry. Greenwood quickly debunked the “bubble” rumor by explaining the index continues to move up year over year and it is driven by strong science that results in strong returns and that increasing sophistication among investors allows them to more accurately assess company valuations than in the past. Further, Greenwood addressed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers


The 17th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place last week in New York City at the Waldorf Astoria with more than 1,400 registrants, including 620 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 5 fireside chats with biotech and pharma CEOs as well as nearly 170 company presentations. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Fireside Chats with Five CEOs Featured at Day Two of the BIO CEO & Investor Conference


Fireside Chat with John F. Milligan, PhD, President & COO, Gilead Sciences The first fireside chat of the BIO CEO and Investor Conference featured John F. Milligan, Ph.D. President & COO of Gilead Sciences.  In a session moderated by Barclays analyst Geoff Meacham, Dr. Milligan was optimistic that sales of Gilead’s Hepatitis C treatments would see expanded sales volumes as more providers become comfortable with the regimens and treating HCV patients, according to Milligan. He Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Patients Remain the Focus for the Future of Personalizing Oncology


The 17th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria in New York City, kicked off this morning with an interactive panel of industry heavyweights discussing the growing trend to personalize oncology treatments with molecular diagnostics. Moderated by Michael King, Managing Director, Senior Research Analyst, JMP Securities. Michael helped steer the group of experts as they discussed enabling broader matching of patient-cancer-therapy, lessons learned from the Cancer Genome Atlas and the potential Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,